• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    ARCA biopharma, Inc. (ABIO)

    -NasdaqCM
    4.10 Down 0.04(0.97%) 4:00PM EDT
    Prev Close:4.14
    Open:4.10
    Bid:4.09 x 100
    Ask:4.10 x 200
    1y Target Est:16.50
    Beta:0.659198
    Next Earnings Date:N/A
    Day's Range:4.00 - 4.22
    52wk Range:3.05 - 10.85
    Volume:22,012
    Avg Vol (3m):24,060
    Market Cap:37.17M
    P/E (ttm):N/A
    EPS (ttm):-2.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABIO

    Comparison

    Symbol% ChgMkt Cap
    ABIODown 0.97%37.17M
    AZNDown 1.23%73.11B
    GSKDown 0.35%104.40B
    ILIUDown 6.67%24.21M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback